SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Concerning Whether the Sale of Impax Laboratories, Inc. to Amneal Pharmaceuticals LLC is Fair to Shareholders

NEW YORK--(BUSINESS WIRE)--The following statement is being issued by Levi & Korsinsky, LLP:

To: All Persons or Entities who purchased Impax Laboratories, Inc. (“Impax” or the “Company”) (NASDAQ: IPXL) stock prior to October 17, 2017.

You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into the fairness of the sale of Impax to Amneal Pharmaceuticals LLC. Under the terms of the transaction, shareholders of Impax will receive shares in Amneal and ultimately own approximately 25% of the new company’s pro forma shares. To learn more about the action and your rights, go to:

http://www.zlkdocs.com/IPXL-Info-Request-Form-ma-6156

or contact Joseph E. Levi, Esq. either via email at [e-mail] or by telephone at [phone], toll-free: [phone]. There is no cost or obligation to you.

Levi & Korsinsky is a national firm with offices in New York, Connecticut, California, and Washington D.C. The firm's attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities lawsuits and have recovered hundreds of millions of dollars for aggrieved shareholders. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.